Panacea Biotec Limited (PANACEABIO.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 18.07B |
| Enterprise Value | 17.66B |
| P/E Ratio | -595.57 |
| PEG Ratio | 1.67 |
| Price/Sales Ratio | 5.02 |
| Price/Book Ratio | 4.08 |
| Enterprise/Revenue | 4.95 |
| Enterprise/EBITDA | 147.9 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.01 |
| Operating Margin | -0.06 |
AD
Management Effectiveness
| Return On Assets | -0 |
| Return On Equity | -0.01 |
Income Statement
| Revenue | 6.4B |
| Revenue/Share | 98.43 |
| Gross Profit | 1.45B |
| EBITDA | -46.6M |
| Net Income | -53.7M |
| Diluted EPS | -0.88 |
Balance Sheet
| Total Cash | 744M |
| Total Cash/Share | 11.45 |
| Total Debt | 236.6M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 1.47 |
| Book Value Per Share | 127.52 |
Price History
| 52-Week Change | 26.27 |
| 52-Week High | 647 |
| 52-Week Low | 292.4 |
| Moving Average 50 Days | 422.26 |
| Moving Average 200 Days | 386.84 |
Statistics
| Average Volume | 747,922 |
| Shares Outstanding | 61.25M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 10:1 |
| Last Split Date | February 03, 2003 |
AD
